Literature DB >> 191469

Isolation of simian virus 40 from a newborn child.

G Brandner, A Burger, D Neumann-Haefelin, C Reinke, H Helwig.   

Abstract

Rubella virus and simina virus 40 (SV40) were isolated from a newborn child suffering from neurological and anatomical anomalies. The SV40 isolate was very similar to SV40 strain 777 by electron microscopic, biological, and immunological criteria.

Entities:  

Mesh：

Year:  1977        PMID： 191469      PMCID： PMC274571          DOI： 10.1128/jcm.5.2.250-252.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Simian virus 40-related antigens in three human meningiomas with defined chromosome loss.

Authors:  A F Weiss; R Portmann; H Fischer; J Simon; K D Zang
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Simian virus 40 in a human cancer.

Authors:  F Soriano; C E Shelburne; M Gökcen
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

3.  The nucleic acid of an SV40-like virus isolated from a patient with progressive multifocal leukoencephalopathy.

Authors:  G H Sack; O Narayan; K J Danna; L P Weiner; D Nathans
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

4.  Evidence for an SV40-related papovavirus infection of man.

Authors:  K V Shah
Journal:  Am J Epidemiol       Date:  1972-03       Impact factor: 4.897

5.  Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy.

Authors:  L P Weiner; R M Herndon; O Narayan; R T Johnson; K Shah; L J Rubinstein; T J Preziosi; F K Conley
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

6.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

7.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321
  7 in total
  7 in total

1.  Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.

Authors:  J A Lednicky; A S Arrington; A R Stewart; X M Dai; C Wong; S Jafar; M Murphey-Corb; J S Butel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

3.  Herpes simplex virus infection generates large tandemly reiterated simian virus 40 DNA molecules in a transformed hamster cell line.

Authors:  B Matz
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

5.  Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Authors:  Katharina Leithner; Andreas Leithner; Heimo Clar; Andreas Weinhaeusel; Roman Radl; Peter Krippl; Peter Rehak; Reinhard Windhager; Oskar A Haas; Horst Olschewski
Journal:  Orphanet J Rare Dis       Date:  2006-11-07       Impact factor: 4.123

6.  Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: epitope mapping, papova virus cross-reaction and cell surface staining.

Authors:  R K Ball; B Siegl; S Quellhorst; G Brandner; D G Braun
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

7.  Detection of Japanese eel endothelial cells-infecting virus in Anguilla japonica elvers.

Authors:  Sachiko Okazaki; Shinya Yasumoto; Satoshi Koyama; Shinobu Tsuchiaka; Yuki Naoi; Tsutomu Omatsu; Shin-Ichi Ono; Tetsuya Mizutani
Journal:  J Vet Med Sci       Date:  2015-12-17       Impact factor: 1.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.